183490 — Enzychem Lifesciences Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩149bn
- KR₩19bn
- KR₩76bn
- 17
- 31
- 82
- 36
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 45,421 | 90,504 | 94,587 | 192,856 | 137,226 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 9,527 | 4,786 | 6,107 | 10,510 | 21,362 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 63,236 | 104,999 | 109,783 | 220,313 | 174,475 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 14,813 | 15,669 | 15,431 | 23,294 | 26,164 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 84,991 | 123,802 | 133,084 | 247,555 | 211,546 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7,499 | 9,784 | 53,621 | 42,284 | 14,154 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 10,951 | 51,320 | 58,422 | 45,811 | 18,030 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 74,041 | 72,483 | 74,662 | 201,744 | 193,516 |
Total Liabilities & Shareholders' Equity | 84,991 | 123,802 | 133,084 | 247,555 | 211,546 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |